HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Binx STI Test Kits Move From POC To At-Home Through Walgreens

Executive Summary

Binx Health's collection kits include tests for chlamydia, gonorrhea, syphilis, HIV, HPV and other common sexually transmitted infections, which may have accelerated because COVID-19 pandemic “has greatly affected access to in-person STI testing."

You may also be interested in...



Nurish by Nature Made Capitalizes First Year With Brand, Packaging Redesign, Ashwagandha Launch

Brand’s management says its packaging redesign “was inspired by the Nature Made heritage and Nurish mission that healthy living should be joyful.” It partnered with branding consultancy Spicefire to develop brand and packaging to evoke Pharmavite’s 50 years of providing supplements.

Natural Alternatives International First To Clear NPA's, Retailers' Safety, Compliance Standards

Contract manufacturer showed compliance with Supplement Safety & Compliance Initiative standards to globally harmonize benchmarks for natul products. Retailers including Amazon and Walmart acknowledge SSCI as benchmarks companies must meet in order to sell products on their platforms.

Sales Grow Across C&D's Products And Regions, But Increasing Supply Costs Stunt Income

Raw material supplies slowed during January-March period by catastrophic freeze in Texas and shortage of shipping containers partly due to Suez Canal blockage. "We're absorbing $90 million of incremental costs for the full year,” says CFO Ronald Dierker.

Topics

UsernamePublicRestriction

Register

RS151268

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel